WT1 peptide vaccination in combination with imatinib therapy for a patient with CML in the chronic phase.
Narita M, Masuko M, Kurasaki T, Kitajima T, Takenouchi S, Saitoh A, Watanabe N, Furukawa T, Toba K, Fuse I, Aizawa Y, Kawakami M, Oka Y, Sugiyama H, Takahashi M.
Narita M, et al.
Int J Med Sci. 2010 Apr 20;7(2):72-81. doi: 10.7150/ijms.7.72.
Int J Med Sci. 2010.
PMID: 20428337
Free PMC article.